Results 171 to 180 of about 11,492 (193)

Bletilla striata oligosaccharides alleviate high-fat diet-induced metabolic associated fatty liver in mice through modulation of gut microbiota and host metabolism. [PDF]

Front Nutr
Lei K, Li J, Wei K, Bai Y, Mao J, Su Z.
europepmc   +1 more source

Mangiferin alleviates metabolic-associated fatty liver disease by modulating gut microbiota and FXR signaling pathway to regulate bile acid metabolism. [PDF]

Front Pharmacol
Zheng L, Xie Q, Yao S, Chen M, Zhao W, Li R, Cheng J, Zhang Y.   +7 more
europepmc   +1 more source

<i>Helicobacter pylori</i> and metabolic-associated fatty liver disease severity: a meta-analysis. [PDF]

Front Med (Lausanne)
Zhang L, Zhang Y, Qiao L, Wu R, He F, Guan Y, Li L.   +6 more
europepmc   +1 more source

Quantifying the metabolic-inflammatory axis: synergistic value of TyG index and FAI in assessing CAD risk among MAFLD patients. [PDF]

Front Endocrinol (Lausanne)
Bai X, Wang Z, Cao Z, Zhen J.
europepmc   +1 more source

MAFLD and risk of CKD

Metabolism: Clinical and Experimental, 2021
Background/aims: Whereas nonalcoholic fatty liver disease (NAFLD) is a multisystem disease, the association between metabolic dysfunction-associated fatty liver disease (MAFLD) and extra-hepatic diseases is not known.
Rafael S Rios, Christopher D Byrne, Kenneth I Zheng   +2 more
exaly   +2 more sources

MAFLD: a multisystem disease [PDF]

Therapeutic Advances in Endocrinology and Metabolism, 2023
Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and more than 50% of dysmetabolic patients, is an emerging cause of chronic liver disease and its complications.
Salvatore Petta, Rosaria Maria Pipitone, Stefania Grimaudo   +2 more
exaly   +2 more sources

Diet, oxidative stress and MAFLD: a mini review [PDF]

Frontiers in Nutrition
Globally, metabolic dysfunction-associated fatty liver disease (MAFLD), also known as non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), is a common chronic liver disease.
Liang Qiao, Zenan Hu
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD

Clinical Gastroenterology and Hepatology, 2021
Michael Le, Ramsey Cheung, Mindie Nguyen   +2 more
exaly  

Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?

Journal of Hepatology, 2021
Wenhua Ling, Shen Chen
exaly  

Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups

Liver International, 2022
Loes Alferink, Qiuwei Pan, Robert de Knegt   +2 more
exaly